|
Three Nature Medicine Articles on BET inhibitors and Prostate Cancer
|
6
|
Zenith Epigenetics
|
Aug 15, 2017 10:42AM
|
|
Re: Did someone already post this?
|
9
|
Resverlogix Corp.
|
Aug 16, 2017 02:00PM
|
|
Re: Did someone already post this?
|
3
|
Resverlogix Corp.
|
Aug 16, 2017 04:35PM
|
|
Re: Did someone already post this?
|
8
|
Resverlogix Corp.
|
Aug 17, 2017 11:26AM
|
|
Re: Did someone already post this?
|
5
|
Resverlogix Corp.
|
Aug 17, 2017 11:47AM
|
|
Re: Did someone already post this?
|
6
|
Resverlogix Corp.
|
Aug 17, 2017 04:23PM
|
|
Re: Did someone already post this?
|
5
|
Resverlogix Corp.
|
Aug 18, 2017 02:22PM
|
|
biOasis Appoints Doug Williams, MBA, EVP, CBO
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 21, 2017 10:30AM
|
|
Re: biOasis Appoints Doug Williams, MBA, EVP, CBO
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 21, 2017 10:35AM
|
|
96 hours
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 11:02AM
|
|
Re: 96 hours
|
1
|
Resverlogix Corp.
|
Aug 22, 2017 11:25AM
|
|
Re: While we wait, outside items that may be of interest
|
4
|
Resverlogix Corp.
|
Aug 23, 2017 01:00PM
|
|
Re: Value
|
2
|
Zenith Epigenetics
|
Aug 23, 2017 04:37PM
|
|
Re: Attending the meeting
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 23, 2017 04:47PM
|
|
Re: Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial
|
5
|
Resverlogix Corp.
|
Aug 23, 2017 04:57PM
|
|
Re: 96 hours
|
3
|
Resverlogix Corp.
|
Aug 24, 2017 08:18AM
|
|
ESC 2017 Abstracts are up
|
9
|
Resverlogix Corp.
|
Aug 24, 2017 10:25AM
|
|
Re: ESC 2017 Abstracts are up
|
1
|
Resverlogix Corp.
|
Aug 24, 2017 12:17PM
|
|
Re: The weekend or Monday morning?
|
3
|
Resverlogix Corp.
|
Aug 25, 2017 10:13AM
|
|
Re: Entertainment During Wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2017 02:04PM
|
